Back to results
US 2006/0223891 A1Published application
Use of alverine, alone or in combination with a tricyclic antidepressant or an antidepressant which is a specific inhibitor of serotonin reuptake for treatment of depression
AssigneeCerep SA
InventorsJacques Migeon, Frédéric Revah
Life of this patent
Estimating the term…
Abstract
The present invention relates to the utilisation of Alverine or its metabolites, alone or in combination with a tricyclic antidepressant or a specific inhibitor antidepressant of serotonin recapture, for the preparation of pharmaceutical compositions for the treatment of depression.
Claims21
1-20. (canceled)
A method for treating depression comprising the administration of an effective amount of Alverine
- or its metabolites, their salts and their esters, to a subject in need thereof.
Dependencies are inferred from the claim text.